Gastroparesis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Gastroparesis drug candidate development moves forward with new financing - Healio



Gastroparesis drug candidate development moves forward with new financing 
Healio
Biopharmaceutical company Neurogastrx announced it has raised $45 million in Series A financing, which will allow them to bring their lead drug candidate for gastroparesis through proof-of-concept development. ?This is an incredible opportunity for us ...

 


Neurogastrx reels in $45M series A for gastroparesis med - FierceBiotech



FierceBiotech
 
Neurogastrx reels in $45M series A for gastroparesis med 
FierceBiotech
Neurogastrx reels in $45M series A for gastroparesis med. by Amirah Al Idrus |. Jan 5, 2018 11:11am. money. Neurogastrx will use the funds to build out its management team and to bring its lead asset through proof of concept. Share Facebook Twitter ...

 


By the Numbers: The Soaring Cost of Gastroparesis - Gastroenterology & Endoscopy News



Gastroenterology & Endoscopy News
 
By the Numbers: The Soaring Cost of Gastroparesis 
Gastroenterology & Endoscopy News
Hospitalizations for gastroparesis have risen more than 40-fold since the early 1990s, according to a new study that found such cases accounted for more than $600 million in health care spending in 2014. The database analysis, by researchers at Baylor ...

 


Gastroparesis Drugs Market 2017-2021 Analysis by Regional Development Status, Market Size, Market Dynamics ... - GEOPOLMonitor



GEOPOLMonitor
 
Gastroparesis Drugs Market 2017-2021 Analysis by Regional Development Status, Market Size, Market Dynamics ... 
GEOPOLMonitor
The Gastroparesis Drugs Market report forecast 2017-2022 is a professional and detailed study on the present state also focuses on the major drivers, keyword business strategists and effective growth for the key players. Global Gastroparesis Drugs ...

 


Gastroparesis Pipeline Healthcare, Clinical Reviews, Survey Reports 2017 - Otaku Reports



Otaku Reports
 
Gastroparesis Pipeline Healthcare, Clinical Reviews, Survey Reports 2017 
Otaku Reports
Gastroparesis Mechanism of action Insights 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Gastroparesis. The report provides a complete understanding of the pipeline activities covering all ...

and more » 


Gastroparesis Global Clinical Trials Review, H2, 2017 - MilTech



MilTech
 
Gastroparesis Global Clinical Trials Review, H2, 2017 
MilTech
The clinical trial report, ?Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an ...

and more » 


Gastroparesis Drugs Market: Trends and Opportunities for the Industry by 2022 - satPRnews (press release)



Gastroparesis Drugs Market: Trends and Opportunities for the Industry by 2022 
satPRnews (press release)
Gastroparesis Drugs Market Research Report provides a professional and in-depth study of the major Gastroparesis Drugs industry leading players along with the company profiles and strategies adopted by them. This enables the buyer of the report to gain ...

and more » 


Gastroparesis ? Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 - MilTech



Gastroparesis ? Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 
MilTech
Gastroparesis ? Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017? provides comprehensive insights about marketed and Phase III products for the Gastroparesis. The report includes information of marketed products including their ...

and more » 


Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept - PR Newswire (press release)



Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept 
PR Newswire (press release)
BOSTON, Jan. 4, 2018 /PRNewswire/ -- Neurogastrx, Inc., a private biopharmaceutical company focused on discovering and developing therapies for gastrointestinal disorders affecting the enteric nervous system, today announced a transformative $45M ...

 


Gastroparesis Market 2025 Size, Development Status, Type and Application, Segmentation, Forecast by 2025 - Austrian Tribune



Gastroparesis Market 2025 Size, Development Status, Type and Application, Segmentation, Forecast by 2025 
Austrian Tribune
Gastroparesis - Market Insights, Epidemiology and Market Forecast ? 2025? report provides an overview of the disease and in depth research related to Gastroparesis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period ...

and more »